Exploratory analysis of clinical benefit of ipilimumab and nivolumab treatment in patients with metastatic melanoma from a single institution
2021; Springer Science+Business Media; Volume: 24; Issue: 2 Linguagem: Inglês
10.1007/s12094-021-02692-9
ISSN1699-3055
AutoresClara Martínez-Vila, F. Aya Moreno, M. Mugica Estebanez, Gustavo Ares, Guillermo Villacampa, Parisa Dashti, Harleen Oberoi, Roberto Martin-Huertas, Pedro Jares, Llúcia Alós, Cristina Teixidó, R. Rull, Marcelo Sánchez, Josep Malvehy, Esther Carcelero, I. Valduvieco, Argentina Fernández,
Tópico(s)Melanoma and MAPK Pathways
Referência(s)